• Energy Research
• Restricted close
• 3. Good health close
• RU close

This study aims to indicate the importance of revising current health recommendations concerning the duration of exposure and individual sensitivity of the skin to solar ultraviolet (UV) radiation. For this purpose, a 16-year data series (2005-2020) of erythemal radiant exposure (Her) and UV index (UVI) for Serbia was analyzed. The UV-related risk was estimated for lighter skin (skin phototypes I-IV) under prolonged exposure on days when maximum UVI was below the recommended protection threshold (UVIlow days, for UVI < 3). Risk assessment was performed for seasonal exposure using satellite-derived data (OMUVBd product) previously validated by ground-based measurements in Novi Sad. The assessment of harmful effects included an analysis of the relation between the daily maximum UVI and the corresponding daily Her, the occurrence of UVIlow days, the exceedance of minimal erythema dose (MED), and the minimum duration of exposure to induce erythema (tMED) for all lighter skin phototypes. It was found that the share of UVIlow days in the total number of days in Serbia increases with the latitude, with the highest percentage in winter (up to 69.454%) and the lowest in summer (up to 3.468%). The results show that the daily Her frequently exceeded the harmful threshold for lighter skin phototypes I-IV (on average by 91.521, 84.923, 70.556, and 56.515%, respectively) on UVIlow days. It was found that prolonged exposure on days with a maximum of UVI = 2 poses a significant risk of erythema for all lighter skin phototypes, even for a duration of 3 h in the middle of the day, as well as medium risk for UVI = 1, and an absence of risk for UVI = 0. The results suggest that health recommendations should be revised, especially in the mid-latitudes, where the share of UVIlow days is large, and in areas where the population is predominantly lighter-skinned.

AimTo determine the effect of pioglitazone treatment on in vivo and ex vivo muscle mitochondrial function in a rat model of diabetes.MethodsBoth the lean, healthy rats and the obese, diabetic rats are Zucker Diabetic Fatty (ZDF) rats. The homozygous fa/fa ZDF rats are obese and diabetic. The heterozygous fa/+ ZDF rats are lean and healthy. Diabetic Zucker Diabetic Fatty rats were treated with either pioglitazone (30 mg/kg/day) or water as a control (n = 6 per group), for 2 weeks. In vivo 1H and 31P magnetic resonance spectroscopy was performed on skeletal muscle to assess intramyocellular lipid (IMCL) content and muscle oxidative capacity, respectively. Ex vivo muscle mitochondrial respiratory capacity was evaluated using high‐resolution respirometry. In addition, several markers of mitochondrial content were determined.ResultsIMCL content was 14‐fold higher and in vivo muscle oxidative capacity was 26% lower in diabetic rats compared with lean rats, which was, however, not caused by impairments of ex vivo mitochondrial respiratory capacity or a lower mitochondrial content. Pioglitazone treatment restored in vivo muscle oxidative capacity in diabetic rats to the level of lean controls. This amelioration was not accompanied by an increase in mitochondrial content or ex vivo mitochondrial respiratory capacity, but rather was paralleled by an improvement in lipid homeostasis, that is lowering of plasma triglycerides and muscle lipid and long‐chain acylcarnitine content.ConclusionDiminished in vivo muscle oxidative capacity in diabetic rats results from mitochondrial lipid overload and can be alleviated by redirecting the lipids from the muscle into adipose tissue using pioglitazone treatment.